Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies

Piaopiao Zhang,1 Jie Wang,2 Hangbin Hu,1 Sheng Zhang,3 Juying Wei,4 Qing Yang,1 Tingting Qu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Res...

Full description

Bibliographic Details
Main Authors: Zhang P, Wang J, Hu H, Zhang S, Wei J, Yang Q, Qu T
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/clinical-characteristics-and-risk-factors-for-bloodstream-infection-du-peer-reviewed-article-IDR
_version_ 1818130774647373824
author Zhang P
Wang J
Hu H
Zhang S
Wei J
Yang Q
Qu T
author_facet Zhang P
Wang J
Hu H
Zhang S
Wei J
Yang Q
Qu T
author_sort Zhang P
collection DOAJ
description Piaopiao Zhang,1 Jie Wang,2 Hangbin Hu,1 Sheng Zhang,3 Juying Wei,4 Qing Yang,1 Tingting Qu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Respiratory Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 3Infection Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 4Hematological Diseases Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Tingting QuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79# Qingchun East Road, Hangzhou 310001, People’s Republic of ChinaTel/Fax +86 57187236673Email qutingting@zju.edu.cnPurpose: The aim was to examine the clinical characteristics and risk factors for bloodstream infection (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) in patients with hematologic malignancies.Materials and Methods: A single-centre, retrospective case–control study representing 734 patients with hematologic malignancies between January 1, 2017, and December 31, 2018, was conducted. Demographic and clinical data were collected from the hospital electronic medical records system.Results: Among the 734 patients with hematologic malignancies, 3% (22/734) of the patients developed CRKP BSI during their hospitalization. Overall 28-day all-cause mortality reached 77.3% (17/22). Patients with Pitt bacteremia score (PBS) > 4, pneumonia and septic shock were more frequent in the non-survivors versus the survivors. Compared with the non-survivors in antimicrobial treatment, combination therapy of tigecycline and polymyxin B was more common in the survivors. The independent risk factors associated with CRKP BSI were CRKP rectal colonization (OR, 11.067; CI=4.43– 27.644; P< 0.001; 3 points), severe neutropenia (OR, 4.095; CI=0.876– 19.141; P=0.073; 1 point) and invasive mechanical ventilation (IMV) within the previous 30 days to onset of BSI (OR, 18.444; CI=1.787– 190.343; P=0.014; 4 points). The total risk score of ≥ 5 indicated that the probability of CRKP BSI occurrence was above 48%.Conclusion: CRKP BSI in patients with hematologic malignancies is associated with high mortality. The risk factor-based prediction model might help clinicians to start prompt effective anti-infective therapy in patients with suspicion of CRKP BSI and improve outcomes.Keywords: carbapenem-resistant Klebsiella pneumoniae, bloodstream infection, hematologic malignancy, risk factors, prediction
first_indexed 2024-12-11T08:10:23Z
format Article
id doaj.art-f2e053d9451e4fc3b0898254dbe39405
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-11T08:10:23Z
publishDate 2020-09-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-f2e053d9451e4fc3b0898254dbe394052022-12-22T01:14:54ZengDove Medical PressInfection and Drug Resistance1178-69732020-09-01Volume 133233324257243Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic MalignanciesZhang PWang JHu HZhang SWei JYang QQu TPiaopiao Zhang,1 Jie Wang,2 Hangbin Hu,1 Sheng Zhang,3 Juying Wei,4 Qing Yang,1 Tingting Qu1 1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 2Respiratory Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 3Infection Control Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of China; 4Hematological Diseases Department, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People’s Republic of ChinaCorrespondence: Tingting QuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79# Qingchun East Road, Hangzhou 310001, People’s Republic of ChinaTel/Fax +86 57187236673Email qutingting@zju.edu.cnPurpose: The aim was to examine the clinical characteristics and risk factors for bloodstream infection (BSI) due to carbapenem-resistant Klebsiella pneumoniae (CRKP) in patients with hematologic malignancies.Materials and Methods: A single-centre, retrospective case–control study representing 734 patients with hematologic malignancies between January 1, 2017, and December 31, 2018, was conducted. Demographic and clinical data were collected from the hospital electronic medical records system.Results: Among the 734 patients with hematologic malignancies, 3% (22/734) of the patients developed CRKP BSI during their hospitalization. Overall 28-day all-cause mortality reached 77.3% (17/22). Patients with Pitt bacteremia score (PBS) > 4, pneumonia and septic shock were more frequent in the non-survivors versus the survivors. Compared with the non-survivors in antimicrobial treatment, combination therapy of tigecycline and polymyxin B was more common in the survivors. The independent risk factors associated with CRKP BSI were CRKP rectal colonization (OR, 11.067; CI=4.43– 27.644; P< 0.001; 3 points), severe neutropenia (OR, 4.095; CI=0.876– 19.141; P=0.073; 1 point) and invasive mechanical ventilation (IMV) within the previous 30 days to onset of BSI (OR, 18.444; CI=1.787– 190.343; P=0.014; 4 points). The total risk score of ≥ 5 indicated that the probability of CRKP BSI occurrence was above 48%.Conclusion: CRKP BSI in patients with hematologic malignancies is associated with high mortality. The risk factor-based prediction model might help clinicians to start prompt effective anti-infective therapy in patients with suspicion of CRKP BSI and improve outcomes.Keywords: carbapenem-resistant Klebsiella pneumoniae, bloodstream infection, hematologic malignancy, risk factors, predictionhttps://www.dovepress.com/clinical-characteristics-and-risk-factors-for-bloodstream-infection-du-peer-reviewed-article-IDRcarbapenem-resistant klebsiella pneumoniaebloodstream infectionhematologic malignancyrisk factorsprediction
spellingShingle Zhang P
Wang J
Hu H
Zhang S
Wei J
Yang Q
Qu T
Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
Infection and Drug Resistance
carbapenem-resistant klebsiella pneumoniae
bloodstream infection
hematologic malignancy
risk factors
prediction
title Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
title_full Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
title_fullStr Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
title_full_unstemmed Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
title_short Clinical Characteristics and Risk Factors for Bloodstream Infection Due to Carbapenem-Resistant Klebsiella pneumoniae in Patients with Hematologic Malignancies
title_sort clinical characteristics and risk factors for bloodstream infection due to carbapenem resistant klebsiella pneumoniae in patients with hematologic malignancies
topic carbapenem-resistant klebsiella pneumoniae
bloodstream infection
hematologic malignancy
risk factors
prediction
url https://www.dovepress.com/clinical-characteristics-and-risk-factors-for-bloodstream-infection-du-peer-reviewed-article-IDR
work_keys_str_mv AT zhangp clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT wangj clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT huh clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT zhangs clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT weij clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT yangq clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies
AT qut clinicalcharacteristicsandriskfactorsforbloodstreaminfectionduetocarbapenemresistantklebsiellapneumoniaeinpatientswithhematologicmalignancies